Krish S Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity

Krish S Krishnan is President and CEO of Krystal Biotech, Inc.. Currently has a direct ownership of 1.51 Million shares of KRYS, which is worth approximately $207 Million. The most recent transaction as insider was on Dec 29, 2022, when has been sold 8,010 shares (Common Stock) at a price of $80.7 per share, resulting in proceeds of $646,407. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.51M

1.63% 3M change

4.99% 12M change

Total Value Held $207 Million

Krish S Krishnan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2022	SELL Open market or private sale	$646,407 $80.7 p/Share	8,010 Reduced 0.45%	1,769,136 Common Stock
Dec 16 2022	SELL Open market or private sale	$846,817 $80.1 p/Share	10,572 Reduced 0.59%	1,777,146 Common Stock
Nov 23 2022	SELL Open market or private sale	$320 $80.01 p/Share	4 Reduced 0.0%	1,787,718 Common Stock
Nov 08 2022	SELL Open market or private sale	$77,328 $80.05 p/Share	966 Reduced 0.05%	1,787,722 Common Stock
Aug 05 2022	SELL Open market or private sale	$2,033,750 $81.35 p/Share	25,000 Reduced 1.38%	1,788,688 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$290,938 $62.5 p/Share	4,655 Reduced 0.26%	1,813,688 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	-	40,800 Added 2.07%	1,927,262 Common Stock

KSK

Krish S Krishnan

President and CEO

Pittsburgh, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Value

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Krystal Biotech, Inc.

Track Activities on KRYS

Account